Kirin Holdings’ health science-focused arm Kyowa Hakko says the versatility and stability of its postbiotic ingredient has enabled it to continue to enjoy commercial success beyond the surge of COVID-19.
Japanese firm Kirin is expanding its presence in South East Asia with its flagship postbiotic ingredient, with collaborations with major dairy companies underway.
The supplementation of citicoline has shown to significantly improve episodic and overall memory in older adults, according to a 12-week RCT funded by Kyowa Hakko Bio.
A pair of Denver-based entrepreneurs decided to go top shelf on ingredients to launch what they claim is the first chewable dietary supplement product in the recovery space.
The potential bone health benefits of vitamin K2 menaquinone-4 may be achievable at a daily dose of 600 micrograms, according to a new study from Kyowa Hakko with implications for formulations and health.
